Found 0 matching trials
Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia NA This is an open, single-arm, clinical study to evaluate efficacy and safety...
Show More Location
Hebei yanda Ludaopei Hospital
Learn More & Join Trial
Safety and Efficacy of ThisCART22 in Patients With Refractory or Relapsed B Cell Malignancies PHASE1 This is a single-center, nonrandomized, open-label, study to evaluate the s...
Show More Location
The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
Learn More & Join Trial
Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia PHASE1 This is a single center, single arm, open-label pilot study to determine th...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
CARPALL: Immunotherapy With CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic Leukaemia PHASE1 This study aims to evaluate the safety, efficacy and duration of response o...
Show More Location
Great Ormond Street Hospital
Learn More & Join Trial
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies PHASE1 This is a phase I/II trial of T-cell expressing an anti-CD22 Chimeric-Antig...
Show More Location
Sheba Medical Center
Learn More & Join Trial
Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma PHASE1 This is a single arm study to evaluate the efficacy and safety of CD19 and ...
Show More Location
Chongqing University Cancer Hospital
Learn More & Join Trial
Clinical Study of Multi-targeted CAR-T Therapy in Patients With Relapsed/Refractory B-Cell Lymphoma PHASE1 This is a single-arm, open-label clinical study evaluating the efficacy and...
Show More Location
Hebei Yanda Ludaopei Hospital
Learn More & Join Trial
CAR-T for R/R B-NHL PHASE2 This study is a single arm study to investigate the efficacy and safety of ...
Show More Location
the First Affiliated Hospital of Soochow University
Learn More & Join Trial
Study of Anti-CD22 CAR-T Cells Treating Leukemia Children PHASE2 The investigators will conduct a phase II clinical trial of autologous huma...
Show More Location
Beijing Boren Hospital
Learn More & Join Trial
Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL) PHASE1 This is a gene transfer study for patients with a type of blood cancer call...
Show More Location
Texas Children's Hospital
Learn More & Join Trial